🔎 Trials Near Me

Akèy › Glomeruloskleroz fokal segmantè › Kalifòni › Los Angeles

Etid klinik pou Glomeruloskleroz fokal segmantè nan Los Angeles, CA

6 etid pou Glomeruloskleroz fokal segmantè ap chèche patisipan nan sit nan ak bò kote Los Angeles (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

Ap rekriteFaz 2
  • Investigator Site #14, Los Angeles
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07268638

A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

Ap rekriteFaz 3
  • Academic Medical Research Institute - Glendale, Los Angeles
  • Kaiser Permanente - Los Angeles Medical Center, Los Angeles
  • University of California Los Angeles, Los Angeles
Laj 12 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07220083

Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children

Ap rekrite
  • Cedars Sinai Medical Center, Los Angeles
Jiska laj 21 · Tout sèks · Mizajou Aug 28, 2026 · NCT02235857

Nephrotic Syndrome Study Network

Ap rekriteEtid obsèvasyon
  • University of Southern California-Children's Hospital, Los Angeles
Jiska laj 80 · Tout sèks · Mizajou Jun 10, 2026 · NCT01209000

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

Ap rekriteFaz 2
  • Cedars-Sinai Medical Center, Los Angeles
Laj 1 a 17 · Tout sèks · Mizajou May 12, 2026 · NCT05003986

A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

Ap rekriteFaz 3
  • Cedars-Sinai Medical Center, Los Angeles
  • University of California, Los Angeles, Los Angeles
Laj 12 a 80 · Tout sèks · Mizajou Feb 3, 2026 · NCT05183646

Etid Glomeruloskleroz fokal segmantè nan lòt vil

Lòt etid nan Los Angeles

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.